Analyze Diet
PloS one2013; 8(4); e61635; doi: 10.1371/journal.pone.0061635

Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility.

Abstract: Macrocyclic lactones (MLs) represent the major drug class for control of parasitic infections in humans and animals. However, recently reports of treatment failures became more frequent. In addition to human and ruminant parasitic nematodes this also is the case for the horse-nematode Parascaris equorum. Nevertheless, to date the molecular basis of ML resistance is still not understood. Unspecific resistance mechanisms involving transporters such as P-glycoproteins (Pgps) are expected to contribute to ML resistance in nematodes. Here, complete sequences of two P. equorum Pgps were cloned and identified as orthologs of Caenorhabditis elegans Ppg-11 and an unnamed Caenorhabditis briggsae Pgp designated as Pgp-16 using phylogenetic analysis. Quantitative real-time PCR was used to compare expression between tissues. Significantly higher PeqPgp-11 expression was found in the gut for both genders, whereas for PeqPgp-16 the body wall was identified as predominant expression site. Furthermore, Pgps were analyzed regarding their participation in resistance development. Using SeqDoC analyses, Pgp-sequences of P. equorum populations with different ML susceptibility were compared. This approach revealed three single nucleotide polymorphisms (SNPs) causing missense mutations in the PeqPgp-11 sequence which correlated with decreased ML susceptibility. However, no resistance associated differences in mRNA expression levels were detected between embryonated eggs of these populations. In contrast, comparison of two pre-adult groups with different ivermectin (IVM) susceptibility revealed the presence of the three SNPs and in addition statistically significant PeqPgp-11 overexpression in the group of worms with reduced susceptibility. These results indicate that Pgp-11 might be involved in IVM resistance in P. equorum as it shows increased expression in an IVM exposed life-cycle stage of an IVM resistant population as well as occurrence of putatively resistance associated SNPs in populations with reduced IVM susceptibility. These SNPs are promising diagnostic candidates for detection of ML resistance with potential also for other parasitic nematode species.
Publication Date: 2013-04-24 PubMed ID: 23637871PubMed Central: PMC3634834DOI: 10.1371/journal.pone.0061635Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explores the potential role of certain genetic variants of the Parascaris equorum P-glycoprotein-11 in decreasing the effectiveness of a widely used anti-parasitic drug, Ivermectin. Collecting sequences of P-glycoproteins from various sources of infection and analyzing their association with drug resistance, the research identified three specific genetic mutations that appear to contribute to decreased susceptibility to the drug.

Background and Purpose of the Study

  • The study is focused on Macrocyclic lactones (MLs), a major class of drugs used for treating parasitic infections in humans and animals. Overall effectiveness of these drugs is reportedly decreasing.
  • The researchers take a close look at Parascaris equorum, a parasitic nematode specific to horses, which seems to have developed resistance to these drugs.
  • The main aim of the study is to understand the molecular reasons behind this resistance. The researchers hypothesize that the P-glycoproteins (Pgps) present in these parasites somehow contribute to the development of drug resistance.

Methodology

  • The research team clones the complete sequences of two P. equorum P-glycoproteins (PeqPgp-11 and PeqPgp-16), which they identify through phylogenetic analysis.
  • Using real-time PCR, they compare the expression of these sequences in various tissues of the parasite. They discover a higher expression of PeqPgp-11 in the gut and a higher expression of PeqPgp-16 in the body wall.
  • SeqDoC analyses are used to compare Pgp-sequences in populations with varying susceptibility to MLs.

Key Findings

  • Three specific single nucleotide polymorphisms (SNPs), or genetic mutations, in the PeqPgp-11 sequence were found to correlate with reduced susceptibility to MLs.
  • The researchers discovered no significant change in mRNA expression levels between different populations.
  • However, in pre-adult groups with different ivermectin (IVM) susceptibility, the research detected the presence of these three SNPs and also found increased expression of PeqPgp-11 in populations with reduced susceptibility.

Conclusions

  • The study concludes that these three SNPs and overexpression of PeqPgp-11 in the P. equorum nematode might be contributing to its resistance to the IVM drug.
  • The SNPs found in this study are likely to serve as critical diagnostic markers for detecting drug resistance and may also apply to other species of parasitic nematodes.

Cite This Article

APA
Janssen IJ, Krücken J, Demeler J, Basiaga M, Kornaś S, von Samson-Himmelstjerna G. (2013). Genetic variants and increased expression of Parascaris equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility. PLoS One, 8(4), e61635. https://doi.org/10.1371/journal.pone.0061635

Publication

ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 8
Issue: 4
Pages: e61635

Researcher Affiliations

Janssen, I Jana I
  • Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Germany.
Krücken, Jürgen
    Demeler, Janina
      Basiaga, Marta
        Kornaś, Sławomir
          von Samson-Himmelstjerna, Georg

            MeSH Terms

            • ATP Binding Cassette Transporter, Subfamily B / genetics
            • Alleles
            • Animals
            • Antinematodal Agents / pharmacology
            • Ascaridoidea / classification
            • Ascaridoidea / drug effects
            • Ascaridoidea / genetics
            • Drug Resistance / genetics
            • Female
            • Gene Expression
            • Gene Expression Regulation / drug effects
            • Gene Frequency
            • Genetic Variation
            • Horses / parasitology
            • Ivermectin / pharmacology
            • Male
            • Organ Specificity / genetics
            • Phylogeny
            • Polymorphism, Single Nucleotide
            • RNA, Messenger / genetics

            Conflict of Interest Statement

            Competing Interests: The authors have declared that no competing interests exist.

            References

            This article includes 57 references
            1. Campbell WC. History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents.. Curr Pharm Biotechnol 13: 853–865.
              pubmed: 22039784
            2. Sangster NC, Gill J. Pharmacology of anthelmintic resistance.. Parasitol Today 15: 141–146.
              pubmed: 10322335
            3. Wolstenholme AJ, Fairweather I, Prichard R, von Samson-Himmelstjerna G, Sangster NC. Drug resistance in veterinary helminths.. Trends Parasitol 20: 469–476.
              pubmed: 15363440
            4. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus .. PLoS Negl Trop Dis 5: e998.
              pmc: PMC3066159pubmed: 21468315
            5. Beech RN, Skuce P, Bartley DJ, Martin RJ, Prichard RK. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 138: 160–174.
              pmc: PMC3064440pubmed: 20825689
            6. Kerboeuf D, Blackhall W, Kaminsky R, von Samson-Himmelstjerna G. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance.. Int J Antimicrob Agents 22: 332–346.
              pubmed: 13678840
            7. Broeks A, Janssen HW, Calafat J, Plasterk RH. A P-glycoprotein protects Caenorhabditis elegans against natural toxins.. EMBO J 14: 1858–1866.
              pmc: PMC398285pubmed: 7743993
            8. Blackhall WJ, Liu HY, Xu M, Prichard RK, Beech RN. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus .. Mol Biochem Parasitol 95: 193–201.
              pubmed: 9803412
            9. Blackhall WJ, Prichard RK, Beech RN. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles.. Vet Parasitol 152: 101–107.
              pubmed: 18241994
            10. Xu M, Molento M, Blackhall W, Ribeiro P, Beech R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog.. Mol Biochem Parasitol 91: 327–335.
              pubmed: 9566525
            11. Lincke CR, The I, van Groenigen M, Borst P. The P-glycoprotein gene family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences.. J Mol Biol 228: 701–711.
              pubmed: 1360540
            12. Prichard RK, Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development.. Parasitology 134: 1123–1132.
              pubmed: 17608972
            13. Broeks A, Gerrard B, Allikmets R, Dean M, Plasterk RH. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans .. EMBO J 15: 6132–6143.
              pmc: PMC452434pubmed: 8947035
            14. Yan R, Urdaneta-Marquez L, Keller K, James CE, Davey MW. The role of several ABC transporter genes in ivermectin resistance in Caenorhabditis elegans .. Vet Parasitol 190: 519–529.
              pubmed: 22840641
            15. Ardelli BF, Stitt LE, Tompkins JB. Inventory and analysis of ATP-binding cassette (ABC) systems in Brugia malayi .. Parasitology 137: 1195–1212.
              pubmed: 20233492
            16. Williamson SM, Wolstenholme AJ. P-glycoproteins of Haemonchus contortus: development of real-time PCR assays for gene expression studies.. J Helminthol 86: 1–7.
              pubmed: 21729384
            17. Kwa MS, Okoli MN, Schulz-Key H, Okongkwo PO, Roos MH. Use of P-glycoprotein gene probes to investigate anthelmintic resistance in Haemonchus contortus and comparison with Onchocerca volvulus .. Int J Parasitol 28: 1235–1240.
              pubmed: 9762570
            18. Sangster NC, Bannan SC, Weiss AS, Nulf SC, Klein RD. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins.. Exp Parasitol 91: 250–257.
              pubmed: 10072327
            19. Drogemuller M, Schnieder T, von Samson-Himmelstjerna G. Evidence of p-glycoprotein sequence diversity in cyathostomins.. J Parasitol 90: 998–1003.
              pubmed: 15562598
            20. Dicker AJ, Nisbet AJ, Skuce PJ. Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta .. Int J Parasitol 41: 935–942.
              pubmed: 21683705
            21. Huang YJ, Prichard RK. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus .. Mol Biochem Parasitol 102: 273–281.
              pubmed: 10498183
            22. Reinemeyer CR. Diagnosis and control of anthelmintic-resistant Parascaris equorum .. Parasit Vectors 2 Suppl 2S8.
              pmc: PMC2751844pubmed: 19778469
            23. Reinemeyer CR. Anthelmintic resistance in non-strongylid parasites of horses.. Vet Parasitol 185: 9–15.
              pubmed: 22078748
            24. von Samson-Himmelstjerna G, Traversa D, Demeler J, Rohn K, Milillo P. Effects of worm control practices examined by a combined faecal egg count and questionnaire survey on horse farms in Germany, Italy and the UK.. Parasit Vectors 2 Suppl 2S3.
              pmc: PMC2751839pubmed: 19778464
            25. Hejmadi MV, Jagannathan S, Delany NS, Coles GC, Wolstenholme AJ. L-glutamate binding sites of parasitic nematodes: an association with ivermectin resistance?. Parasitology 120 (Pt 5): 535–545.
              pubmed: 10840983
            26. Rohrer SP, Birzin ET, Eary CH, Schaeffer JM, Shoop WL. Ivermectin binding sites in sensitive and resistant Haemonchus contortus .. J Parasitol 80: 493–497.
              pubmed: 8195956
            27. Njue AI, Hayashi J, Kinne L, Feng XP, Prichard RK. Mutations in the extracellular domains of glutamate-gated chloride channel alpha3 and beta subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity.. J Neurochem 89: 1137–1147.
              pubmed: 15147506
            28. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM. Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus .. Mol Biochem Parasitol 180: 99–105.
              pubmed: 21945142
            29. James CE, Davey MW. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans .. Int J Parasitol 39: 213–220.
              pubmed: 18708066
            30. Miller CM, Waghorn TS, Leathwick DM, Gilmour ML. How repeatable is a faecal egg count reduction test?. N Z Vet J 54: 323–328.
              pubmed: 17151732
            31. Lespine A, Ménez C, Bourguinat C, Prichard RK. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance.. Int J Parasitol: Drug Drug Resist 2: 58–75.
              pmc: PMC3862436pubmed: 24533264
            32. Clayton HM, Duncan JL. The migration and development of Parascaris equorum in the horse.. Int J Parasitol 9: 285–292.
              pubmed: 489235
            33. Darriba D, Taboada GL, Doallo R, Posada D. ProtTest 3: fast selection of best-fit models of protein evolution.. Bioinformatics 27: 1164–1165.
              pmc: PMC5215816pubmed: 21335321
            34. Abascal F, Zardoya R, Posada D. ProtTest: selection of best-fit models of protein evolution.. Bioinformatics 21: 2104–2105.
              pubmed: 15647292
            35. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.. Syst Biol 59: 307–321.
              pubmed: 20525638
            36. Anisimova M, Gil M, Dufayard JF, Dessimoz C, Gascuel O. Survey of branch support methods demonstrates accuracy, power, and robustness of fast likelihood-based approximation schemes.. Syst Biol 60: 685–699.
              pmc: PMC3158332pubmed: 21540409
            37. Le SQ, Gascuel O. An improved general amino acid replacement matrix.. Mol Biol Evol 25: 1307–1320.
              pubmed: 18367465
            38. Crowe ML. SeqDoC: rapid SNP and mutation detection by direct comparison of DNA sequence chromatograms.. BMC Bioinformatics 6: 133.
              pmc: PMC1156871pubmed: 15927052
            39. Grantham R. Amino acid difference formula to help explain protein evolution.. Science 185: 862–864.
              pubmed: 4843792
            40. Aller SG, Yu J, Ward A, Weng Y, Chittaboina S. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.. Science 323: 1718–1722.
              pmc: PMC2720052pubmed: 19325113
            41. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.. Clin Chem 55: 611–622.
              pubmed: 19246619
            42. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data.. Genome Biol 8: R19.
              pmc: PMC1852402pubmed: 17291332
            43. Weisblat DA, Russell RL. Propagation of Electrical Activity in the Nerve Cord and Muscle Syncytium of the Nematode Ascaris lumbricoides .. J Comp Physiol 107: 293–307.
            44. Krause M, Hirsh D. A trans-spliced leader sequence on actin mRNA in C. elegans .. Cell 49: 753–761.
              pmc: PMC7133374pubmed: 3581169
            45. Beech RN, Wolstenholme AJ, Neveu C, Dent JA. Nematode parasite genes: what's in a name?. Trends Parasitol 26: 334–340.
              pubmed: 20478743
            46. Lambert C, Leonard N, De Bolle X, Depiereux E. ESyPred3D: Prediction of proteins 3D structures.. Bioinformatics 18: 1250–1256.
              pubmed: 12217917
            47. Lustigman S, McCarter JP. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.. PLoS Negl Trop Dis 1: e76.
              pmc: PMC2041823pubmed: 17989789
            48. Diawara A, Drake LJ, Suswillo RR, Kihara J, Bundy DA. Assays to detect beta-tubulin codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides .. PLoS Negl Trop Dis 3: e397.
              pmc: PMC2654341pubmed: 19308251
            49. Ardelli BF, Guerriero SB, Prichard RK. Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein.. Mol Biochem Parasitol 143: 58–66.
              pubmed: 15993957
            50. Zhao Z, Sheps JA, Ling V, Fang LL, Baillie DL. Expression analysis of ABC transporters reveals differential functions of tandemly duplicated genes in Caenorhabditis elegans .. J Mol Biol 344: 409–417.
              pubmed: 15522294
            51. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model.. Cell 96: 47–56.
              pubmed: 9989496
            52. Menez C, Mselli-Lakhal L, Foucaud-Vignault M, Balaguer P, Alvinerie M. Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line.. Biochem Pharmacol 83: 269–278.
              pubmed: 22024132
            53. Nielsen MK, Baptiste KE, Tolliver SC, Collins SS, Lyons ET. Analysis of multiyear studies in horses in Kentucky to ascertain whether counts of eggs and larvae per gram of feces are reliable indicators of numbers of strongyles and ascarids present.. Vet Parasitol 174: 77–84.
              pubmed: 20850927
            54. von Samson-Himmelstjerna G, Walsh TK, Donnan AA, Carriere S, Jackson F. Molecular detection of benzimidazole resistance in Haemonchus contortus using real-time PCR and pyrosequencing.. Parasitology 136: 349–358.
              pubmed: 19154653
            55. Kerboeuf D, Guegnard F, Vern YL. Detection of P-glycoprotein-mediated multidrug resistance against anthelmintics in Haemonchus contortus using anti-human mdr1 monoclonal antibodies.. Parasitol Res 91: 79–85.
              pubmed: 12898231
            56. Bourguinat C, Keller K, Bhan A, Peregrine A, Geary T. Macrocyclic lactone resistance in Dirofilaria immitis.. Vet Parasitol 181: 388–392.
              pubmed: 21570194
            57. Bourguinat C, Keller K, Blagburn B, Schenker R, Geary TG. Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype.. Vet Parasitol 176: 374–381.
              pubmed: 21300438